TABLE 5.
Representative ZEs comparison.
| Stents brand | Platform | Polymer coating | Drug (zotarolimus) release | TLR% |
|---|---|---|---|---|
| Endeavour | Co–Cr | PC | 95% released in half month | 5.1 |
| Resolute | Co–Cr | Hydrophobic C10, hydrophilic C19, PVP | 85% elutes in 2 months | 1.1 |
| ZoMaxx | SS-Ti | PC | 90% released in 1 month | 9.4 |
TLR, target lesion revascularization at 1 year, p b 0.001 (Miyazawa et al., 2008).